Aclaris Therapeutics, Inc. of MALVERN, PA, a company, filed a Form D exempt-offering notice with the SEC on 2020-04-08. The offering totals $11.4M, of which $11.0M was reported sold. Industry: Pharmaceuticals.
Showing 25 of 38 people.
| Name | Role | Location |
|---|---|---|
| Andrew Powell | Director | Henderson, KY |
| Bryan Reasons | Director | Wayne, PA |
| Kamil Ali-Jackson | Executive Officer | Wayne, PA |
| David Gordon | Executive Officer | Austin, TX |
| Frank Ruffo | Executive Officer | Malvern, PA |
| Joseph Monahan | Executive Officer | St. Louis, MO |
| Hugh Davis | Director | West Palm Beach, FL |
| Hugh Davis | Executive Officer | West Palm Beach, FL |
| Andrew Schiff | Director | New York, NY |
| Anand Mehra | Director | Wayne, PA |
| James Loerop | Executive Officer | Wayne, PA |
| Neal Walker | Director | Malvern, PA |
| Neal Walker | Executive Officer | Malvern, PA |
| Vincent Milano | Director | Wayne, PA |
| William Humphries | Director | Wayne, PA |
| Kevin Balthaser | Executive Officer | Wayne, PA |
| Christopher Molineaux | Director | Wynnewood, PA |
| Maxine Gowen | Director | Wayne, PA |
| Ketan Patel | Director | Cambridge, MA |
| Stephen Tullman | Director | Malvern, PA |
| Christopher Powala | Executive Officer | Malvern, PA |
| Albert Cha | Director | PALO ALTO, CA |
| Andrew A Schiff | Director | Wayne, PA |
| Stephen A Tullman | Director | Wayne, PA |
| Anand A Mehra | Director | Wayne, PA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2024-12-04 | D | $80.0M | $80.0M |
| 2018-08-13 | D/A | $12.5M | $10.0M |
| 2017-08-14 | D | $12.5M | $10.0M |
| 2016-06-14 | D | $20.0M | $20.0M |
| 2015-09-11 | D | $40.0M | $40.0M |
| 2014-10-08 | D | $21.3M | $10.6M |
| 2012-09-10 | D | $20.9M | $20.9M |